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Supplemental Methods
Lentiviral transduction
The shRNA constructs targeting human FOXM1 were cloned into a pLVTH-GFP vector.
Target sequences are listed in Supplemental Table S4 . Full-length cDNA encoding human FOXM1 (isoform 2) was obtained by RT-PCR from HEK 293 cells and cloned into pCHD-GFP or pCHD-mCherry vectors. The FOXM1 point mutants were generated from the wildtype mCherry-FOXM1 vector by site-directed mutagenesis.
HEK 293 cells were transfected with lentiviral vectors by using CalPhos Mammalian
Transfection Kit (Clontech) according to the manufacturer's instruction. After 3 days of transfection, culture media containing lentivirus were collected and concentrated with ultracentrifugation through a 10% sucrose solution. Viruses were resuspended in 1x Hanks' Balanced Salt Solution (Corning) overnight at 4°C and kept at -80°C before use.
Primary CD34+ cells were transduced by spinoculation with lentivirus at a multiplicity of infection score of 10 after 24 hours in culture. Cells were sorted for GFP or mCherry after 5 days of culture using a BD FACSAida (BD Biosciences) and harvested for downstream assays as indicated in the results.
Flow cytometry
For cell surface flow cytometry, cells were washed with PBS and then incubated with indicated antibodies for 20 minutes at room temperature. After washing, cells were analyzed by FACS. Antibodies against CD71-PE (clone MA712;555537), CD71-APC (clone MA712;551373), CD71-BV421 (clone MA712;562995), CD71-APC-H7 (clone MA712;563671), GlyA-APC (clone GA-R2;551336), GlyA-PE-Cy7 (clone GA-R2;563666), CD33-PE-Cy5 (clone WM53;551377), CD11b-PE (clone ICRF44;555388), CD41a-PE (clone HIP8;555467), CD34-PE (clone581;555822), and CD36-APC (clone CB38;550956) were purchased from BD Biosciences. Antibodies against CD11b-APC (clone ICRF44; 17-0118042) and CD123-PE-Cy7 (clone 6H6;25-1239-42) were purchased from eBioscience. Antibody against CD11b-BV605 (clone ICRF44;301332) was purchased from BioLegend. Antibody against CD49d (Integrin alpha4)-PE (clone MZ18-24A9;130-093-282) was purchased from Miltenyl Biotec. Antibody against Band3-APC was kindly provided by Dr. Xiuli An at NYBC.
For intracellular flow cytometry, cells were fixed in 3.2% paraformaldehyde for 10 minutes at 37°C, and permeabilized with 100% methanol for 30 minutes at -80°C. After washing, cells were incubated with indicated antibodies and then analyzed by FACS. Antibody against FOXM1 (ab55006) was purchased from Abcam. Antibodies against p53 (1C12:Alexa Fluor 647 Conjugate:2533) and H3P-ser10 (11D8: Alexa Fluor 647 Conjugated:650805) were purchased from Cell Signaling and BioLegend, respectively.
Data were collected on a FACS Calibur (BD Biosciences) or a DxP10 (Cytek) flow cytometer and analyzed using FlowJo Software (v.10).
RT-qPCR
Total RNA was extracted by using TRIzol reagent (Invitrogen). 500 ng of total RNA was transcribed into first strand cDNA using the iScript cDNA Synthesis Kit (Bio-Rad). Real time qPCR reaction was run with iQ TM SYBR Green MasterMix (Bio-Rad) using the CFX384 Touch TM Real-Time PCR Detection System (Bio-Rad). 7SL scRNA was used as an internal control. Fold change of mRNA was calculated using the ΔΔC t method. All primer sets used are indicated in Supplemental Table S5 .
Immunoblot analysis
Cells were resuspended with RIPA buffer (50 mM Tris-Cl(pH8.0), 150 mM NaCl, 0.1% SDS, 
Statistical analysis
Data are presented as mean ± s.d. P values for statistical significance were obtained using an unpaired Student t-test. P < 0.05 was considered significant. The data are representative of at least two independent experiments. Table S1 . 3 Phase Liquid Culture System Basic media 0 ~5 days 6 ~ 10 days 11 days ~ x-Vivo15 50ng/ml SCF 50ng/ml SCF 50ng/ml SCF 10% FBS 50ng/ml TPO 50ng/ml TPO 50ng/ml TPO 1x PSG 50ng/ml FLT-3 50ng/ml FLT-3 50ng/ml FLT-3 20ng/ml IL-6 20ng/ml IL-6 20ng/ml IL-6 20ng/ml IL-3 20ng/ml IL-3 20ng/ml IL-3 3U/ml EPO 3U/ml EPO 250g/ml Transferrin 1mg/ml Transferrin Table S2 . Erythroid Medium Basic media 0 ~5 days 6 ~ 10 days 11 days ~ x-Vivo15 50ng/ml SCF 50ng/ml SCF 50ng/ml SCF 10% FBS 20ng/ml IL-3 20ng/ml IL-3 20ng/ml IL-3 1x PSG 0.5U/ml EPO 3U/ml EPO 3U/ml EPO 250g/ml Transferrin 1mg/ml Transferrin Table S3 . Myeloid Medium Basic media 0 day~ x-Vivo15 50ng/ml SCF 10% FBS 50ng/ml TPO 1x PSG 15ng/ml G-CSF 20ng/ml GM-CSF Table S4 . shRNA Sequences shRNA Target Sequence shLuc 
5'-AACGTGCGAGTGTCTAACGG-3' 5'-CCCTCTAGGGGTTTGTGATTCT-3' Figure S1 . Figure S1 . Each cell population expresses its specific cell surface marker. Human cord blood CD34+ hematopoietic progenitor cells were cultured for 6 days or 12 days. At the indicated days, cells were stained with each cell surface marker and sorted. RNA was collected from the indicated populations and analyzed by RT-qPCR. 
Figure S7. FOXM1 downregulation does not affect morphological changes of colonies.
Human cord blood CD34+ cells were transduced with lentivirus carrying shRNA against FOXM1 or Luc control. Cells were sorted for GFP+ at 5 days after transduction. 1000 cells of GFP+ cells were plated in methylcellulose media and cultured. Colonies were imaged using a phase contrast microscope at 5 x magnification. Colonies were counted by an investigator blinded to the conditions. **p<0.01 Human cord blood CD34+ cells were treated with FDI-6. Cells were collected at 5 days after treatment. RNA was collected and analyzed by RT-qPCR. *p<0.05, **p<0.01, ***p<0.001 
